STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVLV
  4. [Form 4] Evolv Technologies Holdings, Inc. Insider Trading Activity

Evolv Technologies insider trades: 360k options exercised, 360k shares sold

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Evolv Technologies Holdings (EVLV): Founder & Chief Growth Officer Anil Chitkara reported option exercises and open‑market sales. On 10/24/2025 and 10/27/2025, he exercised a total of 360,000 stock options at $0.24 and $0.42 per share and sold 360,000 Class A shares at a weighted average price of $8.20. The 10/24 sales occurred within $8.03–$8.34, and the 10/27 sale within $8.13–$8.30.

Following these transactions, he beneficially owned 1,275,100 shares directly. Option footnotes state one grant vested 25% on January 31, 2018 with 36 monthly installments thereafter, and another vested 25% on January 1, 2022 with 36 monthly installments thereafter.

Positive

  • None.

Negative

  • None.
Insider Chitkara Anil
Role Founder & Chief Growth Officer
Sold 360,000 shs ($2.95M)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 85,173 $0.00 --
Exercise Stock Option (Right to Buy) 34,827 $0.00 --
Exercise Class A Common Stock 85,173 $0.24 $20K
Exercise Class A Common Stock 34,827 $0.42 $15K
Sale Class A Common Stock 120,000 $8.20 $984K
Exercise Stock Option (Right to Buy) 70,581 $0.00 --
Exercise Stock Option (Right to Buy) 120,000 $0.00 --
Exercise Stock Option (Right to Buy) 49,419 $0.00 --
Exercise Class A Common Stock 70,581 $0.24 $17K
Exercise Class A Common Stock 120,000 $0.24 $29K
Exercise Class A Common Stock 49,419 $0.42 $21K
Sale Class A Common Stock 70,581 $8.20 $579K
Sale Class A Common Stock 120,000 $8.20 $984K
Sale Class A Common Stock 49,419 $8.20 $405K
Holdings After Transaction: Stock Option (Right to Buy) — 783,324 shares (Direct); Class A Common Stock — 1,360,273 shares (Direct)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.34. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.13 to $8.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vested and became exercisable as to 25% of the underlying shares on January 31, 2018 and in 36 equal monthly installments thereafter. The stock option vested and became exercisable as to 25% of the underlying shares on January 1, 2022 and in 36 equal monthly installments thereafter.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chitkara Anil
(Last) (First) (Middle)
C/O EVOLV TECHNOLOGIES HOLDINGS, INC.
500 TOTTEN POND ROAD, 4TH FLOOR
(Street)
WALTHAM MA 02451
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Evolv Technologies Holdings, Inc. [ EVLV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Founder & Chief Growth Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/24/2025 M 70,581 A $0.24 1,345,681 D
Class A Common Stock 10/24/2025 M 120,000 A $0.24 1,465,681 D
Class A Common Stock 10/24/2025 M 49,419 A $0.42 1,515,100 D
Class A Common Stock 10/24/2025 S 70,581 D $8.2(1) 1,444,519 D
Class A Common Stock 10/24/2025 S 120,000 D $8.2(1) 1,324,519 D
Class A Common Stock 10/24/2025 S 49,419 D $8.2(1) 1,275,100 D
Class A Common Stock 10/27/2025 M 85,173 A $0.24 1,360,273 D
Class A Common Stock 10/27/2025 M 34,827 A $0.42 1,395,100 D
Class A Common Stock 10/27/2025 S 120,000 D $8.2(2) 1,275,100 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $0.24 10/24/2025 M 70,581 (3) 09/13/2027 Class A Common Stock 70,581 $0 988,497 D
Stock Option (Right to Buy) $0.24 10/24/2025 M 120,000 (3) 09/13/2027 Class A Common Stock 120,000 $0 868,497 D
Stock Option (Right to Buy) $0.42 10/24/2025 M 49,419 (4) 01/10/2031 Class A Common Stock 49,419 $0 611,795 D
Stock Option (Right to Buy) $0.24 10/27/2025 M 85,173 (3) 09/13/2027 Class A Common Stock 85,173 $0 783,324 D
Stock Option (Right to Buy) $0.42 10/27/2025 M 34,827 (4) 01/10/2031 Class A Common Stock 34,827 $0 576,968 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.34. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.13 to $8.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The stock option vested and became exercisable as to 25% of the underlying shares on January 31, 2018 and in 36 equal monthly installments thereafter.
4. The stock option vested and became exercisable as to 25% of the underlying shares on January 1, 2022 and in 36 equal monthly installments thereafter.
Remarks:
/s/ Rachel Roy, Attorney-in-fact for Anil Chitkara 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

Who filed the Form 4 for EVLV?

Founder & Chief Growth Officer Anil Chitkara filed the report for Evolv Technologies Holdings, Inc.

How many options did EVLV’s insider exercise and at what prices?

He exercised a total of 360,000 stock options at exercise prices of $0.24 and $0.42 on 10/24/2025 and 10/27/2025.

How many EVLV shares were sold and at what prices?

He sold 360,000 Class A shares at a weighted average price of $8.20, with 10/24 trades in the $8.03–$8.34 range and a 10/27 trade in the $8.13–$8.30 range.

What is the insider’s EVLV share ownership after the transactions?

Following the reported transactions, he beneficially owned 1,275,100 shares directly.

What were the vesting terms of the exercised EVLV options?

One grant vested 25% on January 31, 2018 with 36 monthly installments thereafter; another vested 25% on January 1, 2022 with 36 monthly installments thereafter.

Were the EVLV sales reported as weighted average prices?

Yes. The filing reports weighted average prices and notes full trade‑by‑trade details are available upon request.